Marie Barnett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marie Barnett has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Kathleen A. Lynch
School of Global Public Health, New York University , New York, New York
2 shared publications - Kelsey Breen
Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA
2 shared publications Meredith MacGregor
Department of Child and Adolescent Psychiatry and Behavioral Sciences Children's Hospital of Philadelphia Philadelphia Pennsylvania USA
2 shared publications- Thomas M. Atkinson
Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, USA
2 shared publications - Viswatej Avutu
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
2 shared publications - Amanda L. Thompson
Life with Cancer, Inova Schar Cancer Institute, Fairfax, FA, USA
1 shared publication
Latest Publications
- 2 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (9) , 919
Identity among adolescent and young adult cancer survivors: an exploratory qualitative study
- 2 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (9) , 919
Identity among adolescent and young adult cancer survivors: an exploratory qualitative study
- 7 July 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (7) , e70541
Design and Implementation of a Psychotherapy Group Program for Individuals and Families Impacted by Li‐Fraumeni Syndrome: A Pilot Study
Objectives: There is a paucity of evidence‐based psychosocial resources for individuals and families impacted by Li‐Fraumeni Syndrome (LFS). This mixed‐methods study aimed to (1) establish interest in and need for a dedicated LFS psychotherapy group, (2) design and implement a psychotherapy group, and (3) evaluate participant experiences and gather feedback for future group interventions. Methods: Eligible participants were English‐speaking, ≥ 18 years, and an individual with LFS or a caregiver/family member. An anonymous needs assessment survey determined preferences, formatting and content for a psychotherapy group. Sixteen virtual psychotherapy groups were conducted between September 2020 and April 2024. Semi‐structured post‐group interviews assessed group experience and perceived utility. Results: Majority (77.4%) of survey participants ( N = 31) reported difficulty finding support. Participants aged 18–39 were significantly more interested than those aged ≥ 40 in discussing themes such as family planning ( p < 0.001), communication with children ( p = 0.038), psychosocial support needs ( p = 0.004), couple dynamics ( p < 0.001), and body image and identity ( p = 0.014). A total of 34 individuals joined at least one group, with an average of 6.2 participants/group (range 0–12). Thematic analysis of interviews ( N = 14) demonstrated that participants found the group constructive and largely endorsed the format and facilitation. Six interview themes were extracted: Community, Support and Connection, Structure and Delivery, Group Topics and Themes, Education, Group Composition, and Fostering Hope. Conclusions: A dedicated LFS psychotherapy group, led by facilitators with LFS and mental health expertise, is an acceptable psychosocial resource offering connection for people with this rare diagnosis. Data provides a format for implementing this intervention at other centers, with potential for future research and improving care.
- 7 July 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (7) , e70541
Design and Implementation of a Psychotherapy Group Program for Individuals and Families Impacted by Li‐Fraumeni Syndrome: A Pilot Study
Objectives: There is a paucity of evidence‐based psychosocial resources for individuals and families impacted by Li‐Fraumeni Syndrome (LFS). This mixed‐methods study aimed to (1) establish interest in and need for a dedicated LFS psychotherapy group, (2) design and implement a psychotherapy group, and (3) evaluate participant experiences and gather feedback for future group interventions. Methods: Eligible participants were English‐speaking, ≥ 18 years, and an individual with LFS or a caregiver/family member. An anonymous needs assessment survey determined preferences, formatting and content for a psychotherapy group. Sixteen virtual psychotherapy groups were conducted between September 2020 and April 2024. Semi‐structured post‐group interviews assessed group experience and perceived utility. Results: Majority (77.4%) of survey participants ( N = 31) reported difficulty finding support. Participants aged 18–39 were significantly more interested than those aged ≥ 40 in discussing themes such as family planning ( p < 0.001), communication with children ( p = 0.038), psychosocial support needs ( p = 0.004), couple dynamics ( p < 0.001), and body image and identity ( p = 0.014). A total of 34 individuals joined at least one group, with an average of 6.2 participants/group (range 0–12). Thematic analysis of interviews ( N = 14) demonstrated that participants found the group constructive and largely endorsed the format and facilitation. Six interview themes were extracted: Community, Support and Connection, Structure and Delivery, Group Topics and Themes, Education, Group Composition, and Fostering Hope. Conclusions: A dedicated LFS psychotherapy group, led by facilitators with LFS and mental health expertise, is an acceptable psychosocial resource offering connection for people with this rare diagnosis. Data provides a format for implementing this intervention at other centers, with potential for future research and improving care.
- Open Access
Biofeedback in Pediatric, Adolescent, and Young Adult Cancer Care: A Systematic Review
Background/Objectives: Biofeedback interventions are increasingly utilized in pediatric and adult care, with evidence in treating specific medical conditions and specific symptoms. However, evidence supporting their efficacy among children and adolescents and young adults (AYAs, aged 15–39) with cancer is limited. The aims of this systematic review are to present, assess, and synthesize the existing research on biofeedback in pediatric and AYA oncology, identify gaps in biofeedback research within this population, and provide recommendations for future research and clinical implications. Methods: A systematic search for articles was conducted using six bibliographic databases—PubMed/MEDLINE (NLM), EMBASE (Elsevier), CINAHL (EBSCO), SPORTDiscus (EBSCO), PsycINFO (OVID), and PEDro (NeuRA)—with an update on 5/7/2025. Included were studies involving pediatric/AYA oncology participants (0–39 years old) and those receiving at least one biofeedback modality. The methodological quality and risk of bias among included articles were assessed using the Cochrane Risk of Bias (ROB) Tool (modified version for non-randomized studies). A narrative synthesis of included studies examined the type of cancer studied, type of biofeedback used, study designs and methodological quality, and key outcomes evaluated. Results: While the literature suggests that biofeedback may offer beneficial outcomes for managing various pediatric/AYA oncology-related symptoms, such as pain, anxiety, and fatigue, only 8 studies out of 1013 screened (<1%) met inclusion criteria. Limitations included low study quality (small sample sizes, lack of control groups, and methodological inconsistencies). Conclusions: While biofeedback shows promise as a feasible and effective intervention, there is a call to action for well-designed, methodologically rigorous studies to substantiate its effectiveness and inform evidence-based practice specifically for pediatric/AYA oncology patients and clinicians.
Open AccessBiofeedback in Pediatric, Adolescent, and Young Adult Cancer Care: A Systematic Review
Background/Objectives: Biofeedback interventions are increasingly utilized in pediatric and adult care, with evidence in treating specific medical conditions and specific symptoms. However, evidence supporting their efficacy among children and adolescents and young adults (AYAs, aged 15–39) with cancer is limited. The aims of this systematic review are to present, assess, and synthesize the existing research on biofeedback in pediatric and AYA oncology, identify gaps in biofeedback research within this population, and provide recommendations for future research and clinical implications. Methods: A systematic search for articles was conducted using six bibliographic databases—PubMed/MEDLINE (NLM), EMBASE (Elsevier), CINAHL (EBSCO), SPORTDiscus (EBSCO), PsycINFO (OVID), and PEDro (NeuRA)—with an update on 5/7/2025. Included were studies involving pediatric/AYA oncology participants (0–39 years old) and those receiving at least one biofeedback modality. The methodological quality and risk of bias among included articles were assessed using the Cochrane Risk of Bias (ROB) Tool (modified version for non-randomized studies). A narrative synthesis of included studies examined the type of cancer studied, type of biofeedback used, study designs and methodological quality, and key outcomes evaluated. Results: While the literature suggests that biofeedback may offer beneficial outcomes for managing various pediatric/AYA oncology-related symptoms, such as pain, anxiety, and fatigue, only 8 studies out of 1013 screened (<1%) met inclusion criteria. Limitations included low study quality (small sample sizes, lack of control groups, and methodological inconsistencies). Conclusions: While biofeedback shows promise as a feasible and effective intervention, there is a call to action for well-designed, methodologically rigorous studies to substantiate its effectiveness and inform evidence-based practice specifically for pediatric/AYA oncology patients and clinicians.
- Top Cited PapersOpen Access
Psychosocial Needs and Preferences for Care among Adolescent and Young Adult Cancer Patients (Ages 15–39): A Qualitative Study
Adolescents and young adults (AYAs) require a multidisciplinary approach to cancer care due to their complex biopsychosocial situations and varied developmental maturity. Currently, age and diagnosis determine referral to pediatric or adult oncology, with differing treatment paradigms and service utilization patterns, contributing to suboptimal improvements in outcomes. Understanding the unique perspectives of AYAs is essential to designing patient-centered AYA services. Thus, we conducted six focus groups with AYAs (n = 25) treated by medical or pediatric oncologists to evaluate: (1) the unique experiences of cancer care as an AYA; (2) AYA-specific information needs and communication preferences; and (3) recommendations for service provision, delivery and accommodations for AYAs. Transcripts were analyzed using inductive thematic content analysis and identified six major themes to inform clinically-actionable recommendations and the development of a patient-reported outcome measure: (1) AYAs experience social isolation and loss of independence; (2) AYAs have an uncertain sense of the future and need conversations around survivorship and long-term and late effects; (3) AYAs desire greater control over discussions with their care team; (4) AYAs need additional navigational and social/caregiver supports; (5) AYAs prefer an inclusive AYA space in the hospital; and (6) LGBTQ+ patients experience distinct concerns as AYA cancer patients. These will form the basis for specific and tailored clinical recommendations to improve AYA cancer care delivery.
Top Cited PapersOpen AccessPsychosocial Needs and Preferences for Care among Adolescent and Young Adult Cancer Patients (Ages 15–39): A Qualitative Study
Adolescents and young adults (AYAs) require a multidisciplinary approach to cancer care due to their complex biopsychosocial situations and varied developmental maturity. Currently, age and diagnosis determine referral to pediatric or adult oncology, with differing treatment paradigms and service utilization patterns, contributing to suboptimal improvements in outcomes. Understanding the unique perspectives of AYAs is essential to designing patient-centered AYA services. Thus, we conducted six focus groups with AYAs (n = 25) treated by medical or pediatric oncologists to evaluate: (1) the unique experiences of cancer care as an AYA; (2) AYA-specific information needs and communication preferences; and (3) recommendations for service provision, delivery and accommodations for AYAs. Transcripts were analyzed using inductive thematic content analysis and identified six major themes to inform clinically-actionable recommendations and the development of a patient-reported outcome measure: (1) AYAs experience social isolation and loss of independence; (2) AYAs have an uncertain sense of the future and need conversations around survivorship and long-term and late effects; (3) AYAs desire greater control over discussions with their care team; (4) AYAs need additional navigational and social/caregiver supports; (5) AYAs prefer an inclusive AYA space in the hospital; and (6) LGBTQ+ patients experience distinct concerns as AYA cancer patients. These will form the basis for specific and tailored clinical recommendations to improve AYA cancer care delivery.
- Open Access
Utilization of Psychotherapeutic Interventions by Pediatric Psychosocial Providers
One of the Standards of Psychosocial Care for Children with Cancer and their Families recommends that all youth with cancer and their family members have access to psychotherapeutic interventions and support throughout the cancer trajectory. This study was created to identify the psychosocial interventions and services provided to children with cancer and their family members, to ascertain whether there are differences in interventions provided by age of the patient and stage of treatment, and to learn about barriers to psychosocial service provision. An online survey was disseminated to psychosocial providers through the listservs of national and international professional organizations. The majority of the 242 respondents were either psychologists (39.3%) or social workers (26.9%) and 79.7% worked in the United States. The intervention offered most often to pediatric patients, caregivers, and siblings, at every stage of treatment, was psychoeducation (41.7–48.8%). Evidence-based interventions, including cognitive behavioral therapy (56.6%) and mindfulness-based interventions (57.9%) were reported to be frequently used with patients. Interventions designed specifically for the pediatric oncology population were not commonly endorsed. Psychosocial providers reported quality of care would be improved by additional staff, better communication/collaboration with medical team members and increased community-based resources. Future research should focus on improving accessibility to population-specific evidenced-based interventions and translating science to practice.
Open AccessUtilization of Psychotherapeutic Interventions by Pediatric Psychosocial Providers
One of the Standards of Psychosocial Care for Children with Cancer and their Families recommends that all youth with cancer and their family members have access to psychotherapeutic interventions and support throughout the cancer trajectory. This study was created to identify the psychosocial interventions and services provided to children with cancer and their family members, to ascertain whether there are differences in interventions provided by age of the patient and stage of treatment, and to learn about barriers to psychosocial service provision. An online survey was disseminated to psychosocial providers through the listservs of national and international professional organizations. The majority of the 242 respondents were either psychologists (39.3%) or social workers (26.9%) and 79.7% worked in the United States. The intervention offered most often to pediatric patients, caregivers, and siblings, at every stage of treatment, was psychoeducation (41.7–48.8%). Evidence-based interventions, including cognitive behavioral therapy (56.6%) and mindfulness-based interventions (57.9%) were reported to be frequently used with patients. Interventions designed specifically for the pediatric oncology population were not commonly endorsed. Psychosocial providers reported quality of care would be improved by additional staff, better communication/collaboration with medical team members and increased community-based resources. Future research should focus on improving accessibility to population-specific evidenced-based interventions and translating science to practice.
- 5 August 2021
- Published by Wiley in Clinical Genetics
- Vol. 101 (2) , 161-182
Psychosocial interventions and needs among individuals and families with Li‐Fraumeni syndrome: A scoping review
Li‐Fraumeni syndrome (LFS), a rare cancer predisposition syndrome caused by germline mutations in the TP53 gene, is associated with significant lifetime risk of developing cancer and warrants extensive and long‐term surveillance. There are psychosocial impacts on individuals and families living with this condition, from the initial diagnosis throughout multiple stages across the lifespan, but these impacts have not been systematically reviewed and organized. The objective of this scoping review was to synthesize and characterize the literature on psychosocial screening and outcomes, educational needs, support services, and available interventions for patients and families with LFS. A systematic search of six databases was most recently conducted in August 2020: (PubMed/MEDLINE (NLM), EMBASE (Elsevier), Cochrane Library (Wiley), CINAHL (EBSCO), PsycINFO (OVID), and Web of Science (Clarivate Analytics). A total of 15 757 titles were screened, and 24 articles included. Several important themes were identified across studies: factors associated with TP53 genetic testing, LFS surveillance, psychological outcomes, and communication. Findings related to these themes were organized into age‐specific categories (age agnostic/across the lifespan, childhood, adolescence and young adulthood, and adulthood).
- 5 August 2021
- Published by Wiley in Clinical Genetics
- Vol. 101 (2) , 161-182
Psychosocial interventions and needs among individuals and families with Li‐Fraumeni syndrome: A scoping review
Li‐Fraumeni syndrome (LFS), a rare cancer predisposition syndrome caused by germline mutations in the TP53 gene, is associated with significant lifetime risk of developing cancer and warrants extensive and long‐term surveillance. There are psychosocial impacts on individuals and families living with this condition, from the initial diagnosis throughout multiple stages across the lifespan, but these impacts have not been systematically reviewed and organized. The objective of this scoping review was to synthesize and characterize the literature on psychosocial screening and outcomes, educational needs, support services, and available interventions for patients and families with LFS. A systematic search of six databases was most recently conducted in August 2020: (PubMed/MEDLINE (NLM), EMBASE (Elsevier), Cochrane Library (Wiley), CINAHL (EBSCO), PsycINFO (OVID), and Web of Science (Clarivate Analytics). A total of 15 757 titles were screened, and 24 articles included. Several important themes were identified across studies: factors associated with TP53 genetic testing, LFS surveillance, psychological outcomes, and communication. Findings related to these themes were organized into age‐specific categories (age agnostic/across the lifespan, childhood, adolescence and young adulthood, and adulthood).
- 30 November 2017
- Published by Taylor & Francis in Journal of Women & Aging
- Vol. 30 (1) , 85-86
Heartthrobs: A history of women and desire, by Carol Dyhouse, Oxford, UK: Oxford University Press, 2017, 262 pp., $27.95 (hardcover), ISBN-13: 978-0198765837/ISBN-10: 0198765835
(2018). Heartthrobs: A history of women and desire, by Carol Dyhouse, Oxford, UK: Oxford University Press, 2017, 262 pp., $27.95 (hardcover), ISBN-13: 978-0198765837/ISBN-10: 0198765835. Journal of Women & Aging: Vol. 30, No. 1, pp. 85-86.
- 30 November 2017
- Published by Taylor & Francis in Journal of Women & Aging
- Vol. 30 (1) , 85-86
Heartthrobs: A history of women and desire, by Carol Dyhouse, Oxford, UK: Oxford University Press, 2017, 262 pp., $27.95 (hardcover), ISBN-13: 978-0198765837/ISBN-10: 0198765835
(2018). Heartthrobs: A history of women and desire, by Carol Dyhouse, Oxford, UK: Oxford University Press, 2017, 262 pp., $27.95 (hardcover), ISBN-13: 978-0198765837/ISBN-10: 0198765835. Journal of Women & Aging: Vol. 30, No. 1, pp. 85-86.